Venous Thrombosis

• 

  Subject Areas on Research

  • A Summary of The 6th International Conference on Coagulation in Liver Disease: Discussion, Debate, Deliberations. 
  • A post-marketing assessment of major bleeding in total hip and total knee replacement surgery patients receiving rivaroxaban. 
  • A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis. 
  • A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. 
  • Abdominopelvic and lower extremity deep venous thrombosis: evaluation with contrast-enhanced MR venography with a blood-pool agent. 
  • Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation. 
  • Acute Achilles Tendon Ruptures. 
  • Acute pulmonary embolism. 
  • An international consensus on the appropriate evaluation and treatment for adults with spinal deformity. 
  • Angiojet rheolytic thrombectomy in infants following cardiac surgery. 
  • Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). 
  • Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab. 
  • Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. 
  • Association between inflammation biomarkers, anatomic extent of deep venous thrombosis, and venous symptoms after deep venous thrombosis. 
  • Asymptomatic Deep Vein Thrombosis is Associated with an Increased Risk of Death: Insights from the APEX Trial. 
  • Bleeding events in bevacizumab-treated cancer patients who received full-dose anticoagulation and remained on study. 
  • Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study. 
  • CT for thromboembolic disease. 
  • CT for thromboembolic disease. 
  • CT of deep venous thrombosis and pulmonary embolus: does iso-osmolar contrast agent improve vascular opacification? 
  • Cancer and thrombosis: back to the future renewed interest in an old problem. 
  • Cancer, clots and consensus: new understanding of an old problem. 
  • Catheter-directed thrombolysis: is it worth the risk? 
  • Cell-based therapy facilitates venous thrombus resolution. 
  • Cerebral venous sinus thrombosis: Incidence of venous thrombosis recurrence and survival. 
  • Characteristics of abdominal vein thrombosis in children and adults. 
  • Chemoembolization for unresectable hepatocellular carcinoma in patients with or without portal vein thrombosis. 
  • Clinical and laboratory evaluation of thrombophilia. 
  • Clinical manifestations of paroxysmal nocturnal hemoglobinuria: present state and future problems. 
  • Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience. 
  • Clinical practice. The evaluation of suspected pulmonary embolism. 
  • Clinical probability and D-dimer testing: how should we use them in clinical practice? 
  • Clinicians' response to radiologists' reports of isolated subsegmental pulmonary embolism or inconclusive interpretation of pulmonary embolism using MDCT. 
  • Coagulation factor XI is a contaminant in intravenous immunoglobulin preparations. 
  • Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. 
  • Combined central retinal vein and artery occlusion associated with an isolated superior ophthalmic vein thrombosis. 
  • Commentary: Deep venous thrombosis in lung transplant recipients-tip of the iceberg that can potentially affect long-term outcome? 
  • Comparative effectiveness of new oral anticoagulants and standard thromboprophylaxis in patients having total hip or knee replacement: a systematic review. 
  • Comparative outcomes of catheter-directed thrombolysis plus anticoagulation versus anticoagulation alone in the treatment of inferior vena caval thrombosis. 
  • Comparative outcomes of catheter-directed thrombolysis plus anticoagulation vs anticoagulation alone to treat lower-extremity proximal deep vein thrombosis. 
  • Comparison of ACCP and AAOS guidelines for VTE prophylaxis after total hip and total knee arthroplasty. 
  • Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study. 
  • Competing risk analysis in a large cardiovascular clinical trial: An APEX substudy. 
  • Compliance with recommended prophylaxis for venous thromboembolism: improving the use and rate of uptake of clinical practice guidelines. 
  • Complication rates of three common spine procedures and rates of thromboembolism following spine surgery based on 108,419 procedures: a report from the Scoliosis Research Society Morbidity and Mortality Committee. 
  • Complications associated with realignment osteotomy of the knee performed simultaneously with additional reconstructive procedures. 
  • Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial. 
  • Contemporary Trends and Comparative Outcomes With Adjunctive Inferior Vena Cava Filter Placement in Patients Undergoing Catheter-Directed Thrombolysis for Deep Vein Thrombosis in the United States: Insights From the National Inpatient Sample. 
  • Cost comparison of strategies for the management of venous thromboembolic event risk following laparotomy for ovarian cancer. 
  • Cost-effectiveness of combination thromboembolism prophylaxis in gynecologic oncology surgery. 
  • Cost-effectiveness of deep venous thrombosis prophylaxis in gynecologic oncology surgery. 
  • Cost-effectiveness of testing for hypercoagulability and effects on treatment strategies in patients with deep vein thrombosis. 
  • Cost-effectiveness of ultrasound in preventing femoral venous catheter-associated pulmonary embolism. 
  • Current techniques to treat pathologic perforator veins. 
  • D-Dimer elevation and adverse outcomes. 
  • D-dimer antigen: current concepts and future prospects. 
  • D-dimer assay predicts mortality in critically ill patients without disseminated intravascular coagulation or venous thromboembolic disease. 
  • DVT: a new era in anticoagulant therapy. 
  • Deep vein thrombosis and pulmonary embolism in pregnancy: diagnosis, complications, and management. 
  • Deep vein thrombosis and pulmonary embolism in the military patient. 
  • Deep vein thrombosis prophylaxis in the moderate- to high-risk patient undergoing lower extremity liposuction. 
  • Deep venous thrombosis and pulmonary thromboembolism: evolving concepts and controversies. Preface. 
  • Delay of transverse rectus abdominis myocutaneous flap reconstruction improves flap reliability in the obese patient. 
  • Delayed diagnosis of iliac vein thrombus in a sexually-active adolescent with Klippel-Trénaunay syndrome. 
  • Development of a clinical prediction model for the postthrombotic syndrome in a prospective cohort of patients with proximal deep vein thrombosis. 
  • Development of a research agenda for endovascular treatment of venous thromboembolism: proceedings from a multidisciplinary consensus panel. 
  • Diagnosis and Management of VTE in Pregnancy. 
  • Diagnosis of a rare source of upper extremity symptoms in a healthy woman after weight lifting. 
  • Donation after cardiac death: the University of Wisconsin experience with liver transplantation. 
  • Duplex ultrasound screening detects high rates of deep vein thromboses in critically ill trauma patients. 
  • Economics of low-molecular weight heparins. 
  • Effectiveness of Intermittent Pneumatic Compression Devices for Venous Thromboembolism Prophylaxis in High-Risk Surgical Patients: A Systematic Review. 
  • Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. 
  • Effects of inherited thrombophilic mutations in an adolescent with antiphospholipid syndrome and systemic lupus erythematosus. 
  • Efficacy of prophylaxis against thromboembolism with intermittent pneumatic compression after primary and revision total hip arthroplasty. 
  • Endoluminal recanalization in a patient with phlegmasia cerulea dolens using a multimodality approach-a case report. 
  • Evaluation of partial and total splenectomy in children with sickle cell disease using an Internet-based registry. 
  • Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients. 
  • Extended-Duration Thromboprophylaxis Among Acute Medically Ill Patients: An Unmet Need. 
  • Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study. 
  • Factors associated with failed retrieval of the Günther Tulip inferior vena cava filter. 
  • Factors that influence perforator thrombosis and predict healing with perforator sclerotherapy for venous ulceration without axial reflux. 
  • Few predictors of massive deep vein thrombosis. 
  • Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II. 
  • For deep vein thrombosis, follow the randomized trials--reply. 
  • Gender differences in the administration of prophylaxis to prevent deep venous thrombosis. 
  • Graduated compression stockings to treat acute leg pain associated with proximal DVT. A randomised controlled trial. 
  • Great saphenous vein stump thrombosis after harvesting for coronary artery bypass graft surgery. 
  • Guidance for the treatment and prevention of obstetric-associated venous thromboembolism. 
  • Guidance for the treatment of deep vein thrombosis and pulmonary embolism. 
  • Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. 
  • Heparin-induced thrombocytopenia: an increasingly common cause of bilateral adrenal hemorrhage. 
  • Hepatocellular carcinoma with intracavitary cardiac involvement: a case report and review of the literature. 
  • High rates of venous thromboembolic events in patients undergoing systemic therapy for urothelial carcinoma: A systematic review and meta-analysis. 
  • High utilization rate of vena cava filters in deep vein thrombosis. 
  • Hospitalized hemorrhagic stroke patients with renal insufficiency: clinical characteristics, care patterns, and outcomes. 
  • Hypercoagulation and thrombophilia in liver disease. 
  • Idarucizumab since FDA approval: Use in the real-world. 
  • Iliac vein thrombosis: feasibility assessment of randomized controlled trials of endovascular pharmacomechanical thrombolysis. 
  • Impact of Institutional Volume on Outcomes of Catheter Directed Thrombolysis in the Treatment of Acute Proximal Deep Vein Thrombosis: A 6-Year US Experience (2005-2010). 
  • Increased risk of deep venous thrombosis with endovascular cooling in patients with traumatic head injury. 
  • Independent Predictors of 30-Day Perioperative Deep Vein Thrombosis in 1346 Consecutive Patients After Spine Surgery. 
  • Indirect CT venography following CT pulmonary angiography: spectrum of CT findings. 
  • Inferior vena cava compression due to massive hydronephrosis from bladder outlet obstruction. 
  • Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post-thrombotic syndrome. 
  • Influence of stroke subtype on quality of care in the Get With The Guidelines-Stroke Program. 
  • Inhibition of Factor Xa : a potential target for the development of new anticoagulants. 
  • Inpatient Consults and Complications During Primary Total Joint Arthroplasty in a Bundled Care Model. 
  • Interval laparoscopic appendectomy for appendicitis complicated by pylephlebitis. 
  • Intravascular ultrasound--guided inferior vena cava filter placement in the military multitrauma patients: a single-center experience. 
  • Introduction to a review series on treatment of venous thrombotic disorders. 
  • Is selective internal radioembolization safe and effective for patients with inoperable hepatocellular carcinoma and venous thrombosis? 
  • Isolated pelvic deep venous thrombosis: relative frequency as detected with MR imaging. 
  • Juvenile idiopathic arthritis and future risk for cardiovascular disease: a multicenter study. 
  • Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis. 
  • Major genetic susceptibility for venous thromboembolism in men: a study of Danish twins. 
  • Maternal Morbidity After Previable Prelabor Rupture of Membranes. 
  • May-Thurner syndrome complicating left-sided donor nephrectomy. 
  • Mechanical calf compression and aspirin prophylaxis for total knee arthroplasty. 
  • Mesenteric vein thrombosis associated with intravaginal contraceptives: a case report and review of the literature. 
  • Mesenteric venous thrombosis. Associated systemic disorders and hypercoagulability status of 21 surgical patients. 
  • Methods of Prospective Investigation of Pulmonary Embolism Diagnosis III (PIOPED III). 
  • Midterm follow-up after pharmacomechanical thrombolysis for lower extremity deep venous thrombosis. 
  • Morbidity associated with sickle cell disease in pregnancy. 
  • More on Venous Thrombosis during Spaceflight. 
  • Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings. 
  • Multidetector computed tomography for acute pulmonary embolism. 
  • Multimodal percutaneous intervention for critical venous occlusive disease. 
  • Multimodality imaging in the diagnosis of deep vein thrombosis and popliteal pseudoaneurysm complicating a sessile osteochondroma. 
  • N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudy. 
  • Neonatal thromboembolic emergencies. 
  • New anticoagulants--the path from discovery to clinical practice. 
  • New classes of anticoagulation and antiplatelet agents: preprocedure management and safety guidelines for imaging-guided intervention. 
  • Nontraditional sites for vascular anastomoses to enable kidney transplantation in patients with major systemic venous thromboses. 
  • Occult Left Common Iliac Vein Compression Increases Postoperative Venous Thromboembolism Risk Following Total Hip Arthroplasty. 
  • Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis. 
  • Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty. 
  • Outcomes and predictors of failure of thrombolysis for iliofemoral deep venous thrombosis. 
  • Ovarian Vein Thrombosis: Incidence of Recurrent Venous Thromboembolism and Survival. 
  • Ovarian vein thrombosis: incidence of recurrent venous thromboembolism and survival. 
  • Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases. 
  • Pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis: safety and feasibility study. 
  • Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brain: high rate of thromboembolic events (CALGB 500102). 
  • Phlebitis, pulmonary emboli and presidential politics: Richard M. Nixon's complicated deep vein thrombosis. 
  • Portal vein thrombosis: an unexpected finding in a 28-year-old male with abdominal pain. 
  • Post-operative pharmacologic thromboprophylaxis after major hepatectomy: does peripheral venous thromboembolism prevention outweigh bleeding risks? 
  • Practice bulletin no. 123: thromboembolism in pregnancy. 
  • Predictive and associative models to identify hospitalized medical patients at risk for VTE. 
  • Predictive factors of thromboembolic events in patients undergoing Roux-en-Y gastric bypass. 
  • Pregnancy, contraception and venous thromboembolism (deep vein thrombosis and pulmonary embolism). 
  • Prevention and management of venous thromboembolism in pregnancy. 
  • Prevention and treatment of deep venous thrombosis. 
  • Progress in MR imaging of the venous system. 
  • Pulmonary embolism. 
  • Pylephlebitis, portal-mesenteric thrombosis, and multiple liver abscesses owing to perforated appendicitis. 
  • Randomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute stroke. 
  • Rapid and progressive venous thrombosis after occlusion of high-flow arteriovenous fistula. 
  • Recognition, prevention, and treatment of home total parenteral nutrition central venous access complications. 
  • Recombinant Human Antithrombin in Pregnant Patients with Hereditary Antithrombin Deficiency: Integrated Analysis of Clinical Data. 
  • Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients. 
  • Risk factors associated with thrombosis in patients with antiphospholipid antibodies. 
  • Risk of deep venous thrombosis and pulmonary embolism in urogynecologic surgical patients. 
  • Risk of venous thromboembolism with use of antipsychotic drugs. 
  • Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness. 
  • Role of platelet inhibition in microvascular surgery. 
  • Role of race and sex in diagnosis and one-year follow up of deep venous thrombosis. 
  • Safety and efficacy of catheter directed thrombolysis in children with deep venous thrombosis. 
  • Sex differences in utilization and outcomes of catheter-directed thrombolysis in patients with proximal lower extremity deep venous thrombosis - Insights from the Nationwide Inpatient Sample. 
  • Simultaneous vs staged bilateral total knee arthroplasty among Medicare beneficiaries, 2000-2009. 
  • Survival among children with portal vein thrombosis and end-stage liver disease. 
  • Technical and patient-related characteristics associated with challenging retrieval of inferior vena cava filters. 
  • Temporary suprarenal inferior vena cava filter for renal biopsy in a patient with renal vein thrombosis. 
  • The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism. 
  • The antiphospholipid syndrome: what are we really measuring? How do we measure it? And how do we treat it? 
  • The diagnosis of acute venous thromboembolism. 
  • The diagnostic approach to acute venous thromboembolism. Clinical practice guideline. American Thoracic Society. 
  • The evolution and impact of the American College of Chest Physicians consensus statement on antithrombotic therapy. 
  • The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event. 
  • The natural history of pelvic vein thrombosis: the natural history of involution? 
  • The pathogenesis of vascular thrombosis and its impact in microvascular surgery. 
  • The pharmacogenetics of coumarin therapy. 
  • The role of continuous passive motion after total knee arthroplasty. 
  • The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial. 
  • The use of antithrombotic therapies in the prevention and treatment of arterial and venous thrombosis: a survey of current knowledge and practice supporting the need for clinical education. 
  • Thromboembolism in hospitalized neutropenic cancer patients. 
  • Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis. 
  • Thrombophilias: when should we test and how does it help? 
  • Thrombosis during pregnancy and the postpartum period. 
  • Thrombus Burden of Deep Vein Thrombosis and Its Association with Thromboprophylaxis and D-Dimer Measurement: Insights from the APEX Trial. 
  • Total shoulder arthroplasty in patients with HIV infection: complications, comorbidities, and trends. 
  • Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs. 
  • Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. 
  • Two instruments to determine activated partial thromboplastin time: implications for heparin monitoring. 
  • Two mechanical devices for prophylaxis of thromboembolism after total knee arthroplasty. A prospective, randomised study. 
  • Ultrasound for Lower Extremity Deep Venous Thrombosis: Multidisciplinary Recommendations From the Society of Radiologists in Ultrasound Consensus Conference. 
  • Understanding the dynamics of thrombin in cardiovascular disease: pathobiology and biochemistry for the clinician. 
  • Unfriendly Filter: An Unusual Cause of Hydronephrosis and Hematuria. 
  • Use of antithrombotic medications among elderly ischemic stroke patients. 
  • Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study. 
  • Vascular artifact mimicking thrombosis on MR imaging using ferumoxytol as a contrast agent in abdominal vascular assessment. 
  • Vena caval filters in pulmonary embolism. 
  • Venous filling defects on portal venous phase CT of the abdomen and pelvis: clinical implications and positive predictive value for diagnosing deep venous thrombosis. 
  • Venous sinus thrombosis in a renal transplant patient. 
  • Venous thromboembolic disease. Clinical practice guidelines in oncology. 
  • Venous thromboembolic disease: where does multidetector computed tomography fit? 
  • Venous thromboembolism debate in joint arthroplasty. 
  • Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. 
  • Venous thromboembolism in intensive care patients. 
  • Venous thromboembolism in patients with diffuse large B-cell lymphoma. 
  • Venous thromboembolism in pregnancy. 
  • Venous thromboembolism in the intensive care unit. 
  • Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. 
  • Venous thromboembolism: diagnosis and current anticoagulation strategies for deep vein thrombosis and pulmonary embolism. 
  • Venous thrombosis and stenosis after implantation of pacemakers and defibrillators. 
  • Venous thrombosis in patients with short- and long-term central venous catheter-associated Staphylococcus aureus bacteremia. 
  • Ventriculoperitoneal shunt failure causing myelopathy in a patient with bilateral jugular vein occlusion. Case report. 
  • Videos in clinical medicine. Central venous catheterization. 
  • We still go for the jugular: implications of the 3SITES central venous catheter study for nephrology. 
  • Whole blood gene expression analyses in patients with single versus recurrent venous thromboembolism. 
  • Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial. 
• 

  Keywords of People

  • Allen, Nancy Bates, Professor Emeritus of Medicine, Medicine, Rheumatology and Immunology
  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Esclamado, Ramon Mitra, Richard Hall Chaney, Sr. Distinguished Professor of Otolaryngology, Surgery, Head and Neck Surgery and Communication Sciences
  • Kim, Charles Yoon, Associate Professor of Radiology, Radiology, Interventional Radiology